Clinical Trial

18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC

Study acronym: PET-Rad-NSCLC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter retrospective study aims to investigate the value of 18F-FDG PET/CT radiomics features in the preoperative precision staging, pathological typing, gene mutation status prediction, and prognostic risk stratification of patients with Non-Small Cell Lung Cancer (NSCLC). The study involves constructing and validating machine learning models to provide imaging-based evidence for individualized precision clinical decision-making.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07449858
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: First Hospital of China Medical University, West China Hospital, Guangdong Second Provincial General Hospital
Conditions Non Small Cell Lung Cancer
Enrollment 500 participants
Start Date 2025-07-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-04